Stock Updates

Today’s Top Gainers in the Market Bristol-Myers Squibb Company (NYSE:BMY) from Healthcare

Today’s top gainers include the company Bristol-Myers Squibb Company (NYSE:BMY) which is in the industry Drug Manufacturers – Major, gaining 0.19% today. In the last week its performance is 3.11%, and 11.59% for the past quarter. Currently, Bristol-Myers Squibb Company, BMY has a target price of 76.48, so today’s gain of 0.19% is a significant step towards its target price. The GAP today is therefore -0.01%.

Bristol-Myers Squibb Company (NYSE:BMY), has a market cap of 123272.34, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 74.40%.

At the current price of 74, it has a dividend yield of 2.06%, and its target price is 76.48. This is with a profit margin of 9.30%, and total debt/equity of 0.47. Bristol-Myers Squibb Company (NYSE:BMY) has a P/E of 78.91, as well as a forward P/E of 22.95.

With a current EPS of 0.94, and a forecasted EPS growth for next year at 25.80%,Bristol-Myers Squibb Company (NYSE:BMY) has had a EPS growth for the past five years at -12.20%. For the next five years EPS growth is projected to be 22.85%.

Performance for the year is 10.77%. Since its IPO date on 06/01/1972, the total performance to date is 8.58%.

Volume today for Bristol-Myers Squibb Company (NYSE:BMY), is 888982, while its average volume is 5920.65. Whilst the total gain today was 0.19%, it did have a day high of -0.97%.

Volatility for this week has been at 1.42%, and 1.62% for the month. The 52-week low for Bristol-Myers Squibb Company, BMY has been 46.12%, while the 52-week-high has reached -0.97%.

Looking at its return of investments, which is 4.60%, and its return on assets is 4.90%. Bristol-Myers Squibb Company (NYSE:BMY) has an operating margin of 11.60%. With a sales growth of 8.70% quarter over quarter. Bearing in mind that Bristol-Myers Squibb Company, BMY is in the sector Healthcare, its long-term debt/equity is 0.46, and has a current ratio of 1.5 and 1.3 for quick ratio.

So what is the value of Bristol-Myers Squibb Company? Well its PEG is 3.45, and the P/S is 7.29, along with a P/B of 8.57. Meanwhile it has a p/cash of 28.62.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment